Liability Insurance For Business Best Deals on Liability Insurance For Business Resources

“Dr. Mehta’s book is a comprehensive and practical overview of all the steps and challenges to successfully develop and commercialize a product from idea to income. His points are illustrated with real life examples throughout. Students and professionals alike should read this book!”
Jim Mullen, CEO Biogen-Idec and past President of the Biotechnology Industry Organization

“The book covers all the things that matter but are never written down in a comprehensive text.”
Carmichael Roberts, General partner at Northbridge Partners, Vice Chairman, WMR Biomedical and cofounder of Surface Logix

“This text covers the commercialization of life science technologies in the areas of pharmaceuticals, biotechnologies, medical devices, and diagnostics, and spanning the development process from invention through marketing and sales. Shreefal Mehta writes clearly and with a practical bent, using case examples and drawing on his own substantial industry experience to help chart a path through the complex landscape of new product development.”
Paul Yock, Director of the Stanford Program in Biodesign and Professor at Stanford Graduate School of Business and School of Medicine

“Shreefal Mehta’s book provides insights and important information about the major steps entrepreneurs must take as an idea progresses through the various steps of commercialization. This text is a must for anyone developing a new medical product.”
Joseph Bronzino, Editor-in-Chief of The Biomedical Engineering Handbook (CRC Press, 3rd Edition, 2006), and recipient of the IEEE Millennium Medal for “his contributions to biomedical engineering research and education”

“Dr Mehta’s book is on my table as a handy reference and overview of the business and product development challenges involved in the health care industry.”
Christoph Hergersberg, Global Technology Leader, Biosciences, General Electric Global Research Center

“Venture philanthropists, venture capitalists, state organizations, and angel investors involved in building new life sciences-based ventures can use this book to inform their investment decision making process. Dr Mehta’s comprehensive book helps funding organizations and entrepreneurs identify the companies and technologies most likely to succeed.”
Lesa Mitchell, Vice President, Advancing Innovation, the Ewing Marion Kauffman Foundation

“Dr Mehta’s book is an excellent guide on how to overcome obstacles in commercializing innovative medical technologies. It covers market research, intellectual property rights, business models, and regulatory affairs. Of note are the real life examples, the extensive discussion of Intellectual Property Rights in relation to business models, and that of interaction with the FDA for innovative projects.”
Dr. Henk van Houten, Senior Vice President Philips Research, Program Manager Healthcare

“This book is a must for starters in the industry and for people who have collected different pieces of the puzzle through scattered sources and need to organize it in their minds to put it in perspective.”
Atul Gupta, MIT Sloan School MBA candidate and Kauffman Foundation intern

“The ‘How-To Bible’ for launching a product – If I had to recommend one great book to get you started on the road to launching a product, then begin with “Commercializing Successful Biomedical Technologies.”
Joe Sasenick, Washington Biotechnology & Biomedical Association

“Shreefal Mehta’s book highlights the right questions to ask in order to truly understand the impact of reimbursement and health economics, too often ignored in product development, on new devices, drugs, and biologicals.”
Parashar Patel, Vice President, Health Economics & Reimbursement, Boston Scientific.

“In Commercializing Successful Biomedical Technologies, biomedical academic and entrepreneur Shreefal Mehta highlights the key issues that must be understood to improve the chance of bringing biomedical technology innovation to market…Mehta does an excellent job of identifying and organizing the major issues associated with biomedical technology commercialization in a framework that students, researchers and entrepreneurs can understand.”
Michael R Bielski, Nature Biotechnology